INS and diabetes mellitus: Metformin is the most commonly used OHA among diabetes patients and its mechanisms are to reduce hepatic glucose output and increase insulin mediated utilization of glucose in the periphery [8, 9], to restore insulin signalling pathways, and to improve insulin sensitivity in peripheral tissues [10].